The analyst firm set a price target for $ expecting FATE to rise to within 12 months (a possible % upside). 24 analyst firms have reported ratings in. Fate Therapeutics, Inc. (FATE) stock forecast and price target · FATEFate Therapeutics, Inc. (%). At close: September 6 PM. Get Fate Therapeutics Inc (FATE:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. According to the 12 analysts' twelve-month price targets for Fate Therapeutics, the average price target is $ The highest price target for FATE is $ Based on analysts offering 12 month price targets for FATE in the last 3 months. The average price target is $ with a high estimate of $10 and a low.
Fate Therapeutics Inc (FATE) ; Volume: 1,, ; Bid/Ask: / ; Day's Range: - Bid Price and Ask Price. The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is. View Fate Therapeutics, Inc. FATE stock quote prices, financial information, real-time forecasts, and company news from CNN. FATE / Fate Therapeutics, Inc. (NasdaqGM) - Forecast, Price Target, Estimates, Predictions ; Projected Stock Price. $ ↑%. Estimated share price by. FATE - Fate Therapeutics - Stock Forecast FATE is currently covered by 18 analysts with an average price target of $ This is a potential upside of $ Fate Therapeutics (FATE) stock price prediction is USD. The Fate Therapeutics stock forecast is USD for September The 11 analysts with month price forecasts for Fate Therapeutics stock have an average target of , with a low estimate of and a high estimate of PROFILE (FATE). Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of. Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing. future price: according to them, FATE price has a max estimate of USD and a min estimate of USD. Watch FATE chart and read a more detailed Fate. Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide.
Revenue is forecast to grow % per year · Earnings are forecast to decline by an average of % per year for the next 3 years · Volatile share price over the. Find the latest Fate Therapeutics, Inc. (FATE) stock quote, history, news and other vital information to help you with your stock trading and investing. Financial PerformanceFate Therapeutics ended the quarter with a cash position of approximately $ million, expected to fund operations through the end of Discover Fate Therapeutics' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. The forecasts for Fate Therapeutics, Inc. (FATE) range from a low of $ to a high of $ The average price target represents a increase of $ from the. Fate Therapeutics Inc (FATE) Q4 Earnings Call Transcript. FATE earnings call for the period ending December 31, Motley Fool Transcribers |. Given the current horizontal trend, you can expect Fate Therapeutics stock with a 90% probability to be traded between $ and $ at the end of this On average, Wall Street analysts predict that Fate Therapeutics's share price could reach $ by Aug 22, The average Fate Therapeutics stock price. The 42 analysts offering price forecasts for Fate Therapeutics have a median target of , with a high estimate of and a low estimate of
Fate Therapeutics FATE share price forecast & targets for Intra Day are , , on the downside, and , , on the upside. Fate Therapeutics. Fate Therapeutics stock price target cut to $8 from $12 at Mizuho. Nov. 20 Fate Therapeutics stock price target cut to $51 from $75 at Truist. Jul. 7. Fate Therapeutics Announces Pricing of $ Million Underwritten Offering and Concurrent Private Placement. SAN DIEGO, March 19, (GLOBE NEWSWIRE) -- Fate. Fate Therapeutics Stock Forecast, FATE stock price prediction. Price target in 14 days: USD. The best long-term & short-term Fate Therapeutics share. (NASDAQ: FATE) Fate Therapeutics currently has ,, outstanding shares. With Fate Therapeutics stock trading at $ per share, the total value of Fate.
Get the latest Fate Therapeutics (FATE) stock forecast for tomorrow and next week. Stay ahead of the game with our Fate Therapeutics stock price prediction. Analysts have set a mean price target forecast of This target is % above the current price. FATE was analyzed by 24 analysts. The buy percentage. Analyst. Target Price. ; Earnings. EPS Forecast. Down ; Investor. New Investor. Deep Track Capital Lp ; Financials. Valuation. High ; Insiders. Largest Sold. Fate Therapeutics Inc Stock Price Forecast, "FATE" Predictons for 1 59% 24 $ GME USW ListePrix des cryptomonnaies en direct 5 year Price Chart Year of Launch Price 24h 7d Market Cap USD EUR GBP Bitcoin. Fate Therapeutics Inc Stock (FATE) Price Forecast for Fate Therapeutics Inc Stock (FATE) is expected to reach an average price of $ in , with a.
How To Get A Credit Increase From Credit One | Best Dental Insurance In Nc